SEC Form 4 · accession 0001209191-16-122623
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Forrest
Officer — COO & CFO
Period of report
May 20, 2016
Accepted (ET)
May 23, 2016 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 20, 2016 | P | 4,356 | $11.53 | A | 58,253 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a weighted average purchase price per share. These shares were purchased in multiple transactions at prices ranging from $11.46 to $11.62.
- F2Includes 2,178 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/20/2016.